National Assembly to revise pharmaceutical affairs law on July 15.

Published: 2000-07-13 14:13:00

Updated: 2000-07-13 14:13:00

The Medical/Pharmacy Separation Subcommittee, National Assembly Health and Welfare Commission took a meeting on July 10 to discuss plans for revision of pharmaceutical affairs law. In the meeting, it was decided to proceed legislation in a joint petition with the accorded bill if the medical, pha...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK